4MT-04

N/A

Report date: 2025/06/11 10:26:22
NME

Base Information

Drug Name4MT-04
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 5 activator 1 inhibitorsNeuroprotectants
TargetsCyclin-dependent kinase 5 activator 1
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4M Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies4M Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A